Martin Prince

ORCID: 0000-0003-1379-7146
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Health disparities and outcomes
  • Mental Health Treatment and Access
  • Aging, Elder Care, and Social Issues
  • Health Systems, Economic Evaluations, Quality of Life
  • Intergenerational Family Dynamics and Caregiving
  • Schizophrenia research and treatment
  • Maternal Mental Health During Pregnancy and Postpartum
  • Global Health Care Issues
  • Chronic Disease Management Strategies
  • Aging and Gerontology Research
  • Child and Adolescent Psychosocial and Emotional Development
  • Global Maternal and Child Health
  • Frailty in Older Adults
  • Health, Environment, Cognitive Aging
  • Liver Disease Diagnosis and Treatment
  • Family Caregiving in Mental Illness
  • Health and Well-being Studies
  • Alzheimer's disease research and treatments
  • Homelessness and Social Issues
  • Migration, Health and Trauma
  • Nutritional Studies and Diet
  • Liver Diseases and Immunity
  • Mental Health and Psychiatry
  • Geriatric Care and Nursing Homes

Manchester University NHS Foundation Trust
2021-2025

King's College London
2016-2025

Oklahoma State University Oklahoma City
2025

Newcastle University
2003-2024

Manchester Royal Infirmary
2012-2024

University of South Alabama Medical Center
2023

Epworth Hospital
2023

University College London
1996-2021

Centre for Mental Health
2007-2021

Addis Ababa University
2020-2021

To acquire an understanding of the societal costs dementia and how they affect families, health social care services, governments to improve lives people with their caregivers.The basic design this study was a societal, prevalence-based, gross cost-of-illness in which were aggregated World Health Organization regions Bank income groupings.The total estimated worldwide US$604 billion 2010. About 70% occurred western Europe North America. In such high-income regions, informal direct contribute...

10.1016/j.jalz.2012.11.006 article EN Alzheimer s & Dementia 2013-01-01
Joshua A. Salomon Theo Vos Daniel R Hogan Michaël Gagnon Mohsen Naghavi and 95 more Ali H. Mokdad Nazma Begum Razibuzzaman Shah Muhammad Karyana Soewarta Kosen Mario Reyna Farje Gilberto Moncada Arup Dutta Sunil Sazawal Andrew R. Dyer Jason Seiler Victor Aboyans Lesley Baker Amanda Baxter Emelia J. Benjamin Kavi Bhalla Aref Bin Abdulhak Fiona Blyth Rupert Bourne Tasanee Braithwaite Peter Brooks Traolach Brugha Claire Bryan-Hancock Rachelle Buchbinder Peter Burney Bianca Calabria Honglei Chen Sumeet S. Chugh Rebecca Smith Cooley Michael H Criqui Marita Cross Kaustubh Dabhadkar Nabila Dahodwala Adrian Davis Louisa Degenhardt Cèsar Díaz‐Torné E. Ray Dorsey Tim Driscoll Karen Edmond Meyer Elbaz Majid Ezzati Valery L. Feigin Cleusa P. Ferri Abraham D Flaxman Louise Flood Marlene Fransen Kana Fuse Belinda J. Gabbe Richard F Gillum Juanita A. Haagsma James Harrison Rasmus Havmoeller Roderick J. Hay Abdullah Hel-Baqui Hans W. Hoek Howard J. Hoffman Emily W. Hogeland Damian Hoy Deborah Jarvis Jost B. Jonas Ganesan Karthikeyan Lisa M. Knowlton Timothy Lathlean Janet L Leasher Stephen S Lim Steven E Lipshultz Alan D López Rafael Lozano Ronan A Lyons Reza Malekzadeh Wagner Marcenes Lyn March David J. Margolis Neil McGill John McGrath George A. Mensah Ana‐Claire Meyer Catherine Michaud Andrew Moran Rintaro Mori Michele E Murdoch Luigi Naldi Charles R. Newton Rosana Norman Saad B Omer Richard H. Osborne Neil Pearce Fernando Perez‐Ruiz Norberto Perico Konrad Pesudovs David Phillips Farshad Pourmalek Martin Prince Jürgen T Rehm Giuseppe Remuzzi

10.1016/s0140-6736(12)61680-8 article EN The Lancet 2012-12-01

Abstract Introduction In 2010, Alzheimer's Disease International presented estimates of the global cost illness (COI) dementia. Since then, new studies have been conducted, and number people with dementia has increased. Here, we present an update estimates. Methods This is a societal, prevalence‐based COI study. Results The worldwide costs were estimated at United States (US) $818 billion in 2015, increase 35% since 2010; 86% occur high‐income countries. Costs informal care direct social...

10.1016/j.jalz.2016.07.150 article EN cc-by Alzheimer s & Dementia 2016-08-29

Background In an 11-country European collaboration, 14 population-based surveys included 21 724 subjects aged ⩾65 years. Most participating centres used the Geriatric Mental State (GMS), but other measures were also used. Aims To derive from these instruments a common depression symptoms scale, EURO–D, to allow comparison of risk factor profiles between centres. Method Common items identified instruments. Algorithms for fitting GMS derived by observation item correspondence or expert...

10.1192/bjp.174.4.330 article EN The British Journal of Psychiatry 1999-04-01

Excess mortality in persons with severe mental disorders (SMD) is a major public health challenge that warrants action. The number and scope of truly tested interventions this area remain limited, strategies for implementation scaling up programmes strong evidence base are scarce. Furthermore, the majority available focus on single or an otherwise limited risk factors. Here we present multilevel model highlighting factors excess SMD at individual, system socio‐environmental levels. Informed...

10.1002/wps.20384 article EN World Psychiatry 2017-01-26

Crick Lund and colleagues describe their plans for the PRogramme Improving Mental health carE (PRIME), which aims to generate evidence on implementing scaling up integrated packages of care priority mental disorders in primary maternal contexts Ethiopia, India, Nepal, South Africa, Uganda.

10.1371/journal.pmed.1001359 article EN cc-by PLoS Medicine 2012-12-27
Coming Soon ...